Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology

Ops! No article found. Reset filter

COVID-19 infectivity profile correction

Viewpoint
Ashcroft P, Huisman JS, Lehtinen S, Bouman JA, Althaus CL, Regoes RR, Bonhoeffer S
Swiss Med Wkly. 2020;150:w20336

Presymptomatic infections are spread over a longer time period before symptom onset than previously thought, which can have significant ramifications for contact tracing efforts.

A research agenda for digital proximity tracing apps

Viewpoint
von Wyl V, Bonhoeffer S, Bugnion E, Puhan MA, Salathé M, Stadler T, Troncoso C, Vayena E, Low N
Swiss Med Wkly. 2020;150:w20324

It is likely that there is only a limited time window for the optimisation of the proximity tracing app and promotion of substantial population uptake. It will be all the more important that research programmes allow data-driven, evidence-based optimisations, and information for the public about the benefits, harms and costs of proximity tracing apps.

Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland

Original article
Lemaitre JC, Perez-Saez J, Azman AS, Rinaldo A, Fellay J
Swiss Med Wkly. 2020;150:w20295

Current estimates of time-varying R0 in Switzerland well below one are promising. However, as of 24 April 2020, at least 96% of the Swiss population remains susceptible to SARS-CoV-2. These results warrant a cautious relaxation of social distance practices and close monitoring of changes in both the basic and effective reproduction numbers.

Time trend of suicide in Swiss male farmers and comparison with other men: a cohort study

Original article
Steck N, Junker C, Bopp M, Egger M, Zwahlen M
Swiss Med Wkly. 2020;150:w20251

The ongoing agricultural reforms present serious challenges for Swiss farmers. This study shows a higher rate of suicide in farmers compared to non-farmers in Switzerland, with the gap widening increasingly after 2006.

Early off-label treatment during pandemics? A dilemma

Viewpoint
Roth JA, Ballouz T, Kouyos RD, Battegay M
Swiss Med Wkly. 2020;150:w20281

Decisions for or against off-label treatment need to be based on clearly defined selection and treatment criteria, a strong biological rationale, a critical appraisal of prior evidence, and the estimated harm-benefit ratio.

icumonitoring.ch: a platform for short-term forecasting of intensive care unit occupancy during the COVID-19 epidemic in Switzerland

Original article
Zhao C, Tepekule B, Criscuolo NG, Wendel Garcia PD, Hilty MP, RISC-19-ICU consortium Investigators in Switzerland, Fumeaux T, Van Boeckel T
Swiss Med Wkly. 2020;150:w20277

In Switzerland, the COVID-19 epidemic is progressively slowing down owing to “social distancing” measures introduced by the Federal Council on 16 March 2020. However, the gradual ease of these measures may initiate a second epidemic wave, the length and intensity of which are difficult to anticipate. The authors introduce icumonitoring.ch, a platform providing hospital-level projections for ICU occupancy.

Reproductive number of the COVID-19 epidemic in Switzerland with a focus on the Cantons of Basel-Stadt and Basel-Landschaft

Original article
Scire J, Nadeau S, Vaughan T, Brupbacher G, Fuchs S, Sommer J, Koch KN, Misteli R, Mundorff L, Götz T, Eichenberger T, Quinto C, Savic M, Meienberg A, Burkard T, Mayr M, Meier CA, Widmer A, Kuehl R, Egli A, Hirsch HH, Bassetti S, Nickel CH, Rentsch KS, Kübler W, Bingisser R, Battegay M, Tschudin-Sutter S, Stadler T
Swiss Med Wkly. 2020;150:w20271

The reproductive number in Switzerland was between 1.5 and 2 during the first third of March, and has consistently decreased to around 1. After the announcement of the latest strict measure on 20 March 2020, namely that gatherings of more than five people in public spaces are prohibited, the reproductive number dropped significantly below 1; the authors of this study estimate the reproductive number to be between 0.6 and 0.8 in the first third of April.

COVID-19 and Iran: swimming with hands tied!

Viewpoint
Gharebaghi R, Heidary F
Swiss Med Wkly. 2020;150:w20242

Like many other countries around the world, Iran is contending with the COVID-19 epidemic, but with the additional burden of international sanctions on supplies of medicines and medical equipment.

COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation

Viewpoint
Salathé M, Althaus CL, Neher R, Stringhini S, Hodcroft E, Fellay J, Zwahlen M, Senti G, Battegay M, Wilder-Smith A, Eckerle I, Egger M, Low N
Swiss Med Wkly. 2020;150:w20225

A liberal approach to testing for SARS-CoV-2 in Switzerland is needed as part of the package of control measures.

Potential impact of seasonal forcing on a SARS-CoV-2 pandemic

Original article
Neher RA, Dyrdak R, Druelle V, Hodcroft EB, Albert J
Swiss Med Wkly. 2020;150:w20224

The authors explore how seasonal variation in transmissibility could modulate a SARS-CoV-2 pandemic. The likely aggregated effect of seasonal variation, infection control measures, and transmission rate variation is a prolonged pandemic wave with lower prevalence at any given time, thereby providing a window of opportunity for better preparation of health care systems.

Verpassen Sie keinen Artikel!

close